Moreover, increased secretion of IL-17 and IFN-γ from T cells has been demonstrated in a transgenic AD mouse model, and treatment with anti-IFN-γ antibody has been shown to attenuate Aβ deposition induced by CD4(+) T cells [66]. This evidence concerns the gene IFNG and Alzheimer disease.